نتائج البحث - "Unité De Prévention"

المساهمون: 1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. drb54@medschl.cam.ac.uk. 2The Netherlands Cancer Institute, Department of Epidemiology (PSOE), Amsterdam, The Netherlands. 3Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. 4Chapel Allerton Hospital, Yorkshire Regional Genetics Service, Leeds, UK. 5Great Ormond Street Hospital for Children NHS Trust, North East Thames Regional Genetics Service, London, UK. 6University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland. 7Inserm U900, Genetic Epidemiology of Cancer team, Paris, France. 8Institut Curie, Paris, France. 9Mines ParisTech, Fontainebleau, France. 10Department of Life & Health Sciences, PSL University, Paris, France. 11Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON, Canada. 12University of Toronto, Department of Molecular Genetics, Toronto, ON, Canada. 13University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Department of Gynaecology and Obstetrics, Kiel, Germany. 14University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Institute of Clinical Molecular Biology, Kiel, Germany. 15University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX, USA. 16Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Unit of Medical Genetics, Department of Medical Oncology and Hematology, Milan, Italy. 17Vall d'Hebron Institute of Oncology, High Risk and Cancer Prevention Group, Barcelona, Spain. 18University Hospital of Vall d'Hebron, Department of Medical Oncology, Barcelona, Spain. 19Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland. 20University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland. 21Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain. 22Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain. 23Centre François Baclesse, Département de Biopathologie, Caen, France. 24Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland. 25University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA, USA. 26Maastricht University Medical Center, Department of Clinical Genetics, Maastricht, The Netherlands. 27IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy. 28Zealand University Hospital, Clinical Genetic Unit, Department of Paediatrics, Roskilde, Denmark. 29Lund University, Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund, Sweden. 30National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary. 31Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA, USA. 32Institute of Genetic Medicine, International Centre for Life, Northern Genetic Service, Newcastle upon Tyne, UK. 33Royal Devon & Exeter Hospital, Department of Clinical Genetics, Exeter, UK. 34ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Hereditary Cancer Program, Barcelona, Spain. 35Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT, USA. 36CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Molecular Oncology Laboratory, Madrid, Spain. 37University Hospital, SOD Genetica Molecolare, Pisa, Italy. 38Peter MacCallum Cancer Center, Melbourne, VIC, Australia. 39The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC, Australia. 40Aarhus University Hospital, Department of Clinical Medicine,, Aarhus, Denmark. 41Columbia University, Departments of Pediatrics and Medicine, New York, NY, USA. 42Ghent University, Centre for Medical Genetics, Ghent, Belgium. 43Institut Curie, Service de Génétique, Paris, France. 44CHU de Besançon, Service de Génétique, Besançon, France. 45Sheffield Children's Hospital, Sheffield Clinical Genetics Service, Sheffield, UK. 46Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA, USA. 47Queen Elizabeth University Hospitals, Department of Clinical Genetics, Glasgow, UK. 48CHU Nantes, Laboratoire de genetique moleculaire, Nantes, France. 49Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands. 50Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands. 51Vall dHebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain. 52University Hospital Vall dHebron, Clinical and Molecular Genetics Area, Barcelona, Spain. 53Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA, USA. 54University of Pennsylvania, Basser Center for BRCA, Abramson Cancer Center, Philadelphia, PA, USA. 55University of Pretoria, Department of Genetics, Arcadia, South Africa. 56Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Genomics Center,, Québec City, QC, Canada. 57The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Oncogenetics Team, London, UK. 58Rigshospitalet, Copenhagen University Hospital, Department of Oncology, Copenhagen, Denmark. 59University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany. 60The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Genomic Medicine, Division of Evolution and Genomic Sciences, Manchester, UK. 61Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Genomic Medicine, North West Genomics hub, Manchester, UK. 62Centre Georges-François Leclerc, Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Dijon, France. 63DHU Dijon, Centre de Génétique, Dijon, France. 64Masaryk Memorial Cancer Institute, Department of Cancer Epidemiology and Genetics, Brno, Czech Republic. 65National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece. 66NHMRC Clinical Trials, ANZ GOTG Coordinating Centre, Camperdown, NSW, Australia. 67Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel. 68Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel. 69Jonsson Comprehensive Cancer Centre, UCLA, Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Los Angeles, CA, USA. 70Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA, USA. 71University Würzburg, Department of Human Genetics, Würzburg, Germany. 72Rigshospitalet, Copenhagen University Hospital, Department of Clinical Genetics, Copenhagen, Denmark. 73CH Niort, Service Régional Oncogénétique Poitou-Charentes, Niort, France. 74Hospices Civils de Lyon, Department of Genetics, Bron, France. 75University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, USA. 76Huntsman Cancer Institute, University of Utah School of Medicine, Department of Dermatology, Salt Lake City, UT, USA. 77Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 78Medical University of Vienna, Dept of OB/GYN, Vienna, Austria. 79Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany. 80Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany. 81German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany. 82St George's NHS Foundation Trust, Southwest Thames Regional Genetics Service, London, UK. 83University Hospital Leipzig, Institute of Human Genetics, Leipzig, Germany. 84The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands. 85Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands. 86University of Münster, Institute of Human Genetics, Münster, Germany. 87Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA. 88NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL, USA. 89The University of Chicago Pritzker School of Medicine, Chicago, IL, USA. 90N.N. Petrov Institute of Oncology, St. Petersburg, Russia. 91Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. 92Guy's and St Thomas' NHS Foundation Trust, Clinical Genetics, London, UK. 93Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland. 94Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC, Australia. 95Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. 96State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. 97Stanford Cancer Institute, Stanford University School of Medicine, Department of Medicine, Division of Oncology, Stanford, CA, USA. 98Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY, USA. 99University of California at Los Angeles, David Geffen School of Medicine, Department of Obstetrics and Gynecology, Los Angeles, CA, USA. 100Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA. 101Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. 102University Medical Center Utrecht, Department of Medical Genetics, Utrecht, The Netherlands. 103Odense University Hospital, Department of Clinical Genetics, Odense, Denmark. 104Cancer Genetics Centre, Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong. 105The University of Hong Kong, Department of Surgery, Pok Fu Lam, Hong Kong. 106Hong Kong Sanatorium and Hospital, Department of Surgery, Happy Valley, Hong Kong. 107Centre Léon Bérard, Unité de Prévention et d'Epidémiologie Génétique, Lyon, France. 108Lyon University, UMR CNRS 5558, Lyon, France. 109Karolinska Institutet, Department of Oncology, Stockholm, Sweden. 110Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 111Centre Antoine Lacassagne, Département d'Hématologie-Oncologie Médicale, Nice, France. 112Amsterdam UMC, location AMC, Department of Clinical Genetics, Amsterdam, The Netherlands. 113University of Munich, Campus Großhadern, Department of Gynecology and Obstetrics, Munich, Germany. 114Radboud University Medical Center, Department of Human Genetics, Nijmegen, The Netherlands. 115Roswell Park Cancer Institute, NRG Oncology, Statistics and Data Management Center, Buffalo, NY, USA. 116Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy. 117Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY, USA. 118University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, ON, Canada. 119University Health Network, Laboratory Medicine Program, Toronto, ON, Canada. 120University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland. 121University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Department of Gynecology and Obstetrics, Düsseldorf, Germany. 122Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark. 123Latvian Biomedical Research and Study Centre, Riga, Latvia. 124Oncogénétique Clinique and Aix Marseille Univ, INSERM, IRD, SESSTIM, Institut Paoli-Calmettes, Département d'Anticipation et de Suivi des Cancers, Marseille, France. 125The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL, USA. 126Birmingham Women's Hospital Healthcare NHS Trust, West Midlands Regional Genetics Service, Birmingham, UK. 127Cambridge University Hospitals NHS Foundation Trust, East Anglian Medical Genetics Service, Cambridge, UK. 128Campus Virchov Klinikum, Charite, Institute of Human Genetics, Berlin, Germany. 129University of Florence, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, Florence, Italy. 130Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, Korea. 131Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, Korea. 132Seoul National University, Cancer Research Institute, Seoul, Korea. 133QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD, Australia. 134Aalborg University Hospital, Molecular Diagnostics, Aalborg, Denmark. 135Aalborg University Hospital, Clinical Cancer Research Center, Aalborg, Denmark. 136Aalborg University, Department of Clinical Medicine, Aalborg, Denmark. 137Portuguese Oncology Institute, Department of Genetics, Porto, Portugal. 138IFOM - the FIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy. 139Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria. 140The University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, VIC, Australia. 141The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, VIC, Australia. 142IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, ProCURE, Barcelona, Spain. 143Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy. 144Klinikum rechts der Isar der Technischen Universität München, Department of Gynaecology and Obstetrics, Munich, Germany. 145University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, NSW, Australia. 146The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW, Australia. 147University of NSW Sydney, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, NSW, Australia. 148Karolinska Institutet, Clinical Genetics, Stockholm, Sweden. 149Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel. 150Yale School of Medicine, Chronic Disease Epidemiology, New Haven, CT, USA. 151Region of Southern Denmark, Vejle Hospital, Department of Clinical Genetics, Vejle, Denmark. 152Wexner Medical Center, The Ohio State University, Department of Gynecology and Obstetrics, Columbus, OH, USA. 153Unité d'Oncogénétique Centre de Lutte contre le Cancer Paul Strauss, Strasbourg, France. 154Institut de Cancérologie Strasbourg Europe, ICANS, Strasbourg, France. 155Université de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, Plateforme GENOMAX, INSERM UMR_S 1109, LabEx TRANSPLANTEX, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de Médecine, Strasbourg, France. 156The Ohio State University, Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, Columbus, OH, USA. 157University of Kansas Medical Center, Department of Internal Medicine, Division of Medical Oncology, Westwood, KS, USA. 158Princess Anne Hospital, Southampton, UK. 159City of Hope, Clinical Cancer Genomics, Duarte, CA, USA. 160Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC, Australia. 161The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC, Australia. 162Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia. 163Hannover Medical School, Institute of Human Genetics, Hannover, Germany. 164INSERM U830, Department of Tumour Biology, Paris, France. 165Université Paris Descartes, Paris, France. 166University Hospital Heidelberg, Institute of Human Genetics, Heidelberg, Germany. 167University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal. 168Cancer Research Malaysia, Breast Cancer Research Programme, Subang Jaya, Selangor, Malaysia. 169University of Malaya, Department of Surgery, Faculty of Medicine, Kuala Lumpur, Malaysia. 170Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA, USA. 171McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC, Canada. 172University of Cambridge, Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. 173The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH, USA. 174University Of Melbourne, Department of Medicine, Melbourne, VIC, Australia. 175Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA, USA. 176Amsterdam UMC, location VUmc, Department of Clinical Genetics, Amsterdam, The Netherlands. 177Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain. 178Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. 179Oxford University Hospitals, Oxford Centre for Genomic Medicine, Oxford, UK. 180University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany. 181Mayo Clinic, Department of Oncology, Rochester, MN, USA. 182Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany. 183Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

المصدر: Genetics in medicine : official journal of the American College of Medical Genetics ; United States

مصطلحات موضوعية: BRCA1/2, PRS, breast cancer, genetics, ovarian cancer, Brjóstakrabbamein, Eggjastokkar, Gen, Breast Neoplasms, Genes, BRCA1, BRCA2, Ovarian Neoplasms

Relation: https://www.nature.com/articles/s41436-020-0862-x; Barnes DR, Rookus MA, McGuffog L, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants [published online ahead of print, 2020 Jul 15]. Genet Med. 2020;10.1038/s41436-020-0862-x. doi:10.1038/s41436-020-0862-x; http://hdl.handle.net/2336/621505; Genetics in medicine : official journal of the American College of Medical Genetics

الاتاحة: http://hdl.handle.net/2336/621505
https://doi.org/10.1038/s41436-020-0862-x

View record in BASE

Full Text Finder

4

Academic Journal

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.

المؤلفون: Qian, Frank, Rookus, Matti A, Leslie, Goska, Risch, Harvey A, Greene, Mark H, Aalfs, Cora M, Adank, Muriel A, Adlard, Julian, Agnarsson, Bjarni A, Ahmed, Munaza, Aittomäki, Kristiina, Andrulis, Irene L, Arnold, Norbert, Arun, Banu K, Ausems, Margreet G E M, Azzollini, Jacopo, Barrowdale, Daniel, Barwell, Julian, Benitez, Javier, Białkowska, Katarzyna, Bonadona, Valérie, Borde, Julika, Borg, Ake, Bradbury, Angela R, Brunet, Joan, Buys, Saundra S, Caldés, Trinidad, Caligo, Maria A, Campbell, Ian, Carter, Jonathan, Chiquette, Jocelyne, Chung, Wendy K, Claes, Kathleen B M, Collée, J Margriet, Collonge-Rame, Marie-Agnès, Couch, Fergus J, Daly, Mary B, Delnatte, Capucine, Diez, Orland, Domchek, Susan M, Dorfling, Cecilia M, Eason, Jacqueline, Easton, Douglas F, Eeles, Ros, Engel, Christoph, Evans, D Gareth, Faivre, Laurence, Feliubadaló, Lidia, Foretova, Lenka, Friedman, Eitan, Frost, Debra, Ganz, Patricia A, Garber, Judy, Garcia-Barberan, Vanesa, Gehrig, Andrea, Glendon, Gord, Godwin, Andrew K, Gómez Garcia, Encarna B, Hamann, Ute, Hauke, Jan, Hopper, John L, Hulick, Peter J, Imyanitov, Evgeny N, Isaacs, Claudine, Izatt, Louise, Jakubowska, Anna, Janavicius, Ramunas, John, Esther M, Karlan, Beth Y, Kets, Carolien M, Laitman, Yael, Lázaro, Conxi, Leroux, Dominique, Lester, Jenny, Lesueur, Fabienne, Loud, Jennifer T, Lubiński, Jan, Łukomska, Alicja, McGuffog, Lesley, Mebirouk, Noura, Meijers-Heijboer, Hanne E J, Meindl, Alfons, Miller, Austin, Montagna, Marco, Mooij, Thea M, Mouret-Fourme, Emmanuelle, Nathanson, Katherine L, Nehoray, Bita, Neuhausen, Susan L, Nevanlinna, Heli, Nielsen, Finn C, Offit, Kenneth, Olah, Edith, Ong, Kai-ren, Oosterwijk, Jan C, Ottini, Laura, Parsons, Michael T, Peterlongo, Paolo, Pfeiler, Georg, Pradhan, Nisha, Radice, Paolo, Ramus, Susan J, Rantala, Johanna, Rennert, Gad, Robson, Mark, Rodriguez, Gustavo C, Salani, Ritu, Scheuner, Maren T, Schmutzler, Rita K, Shah, Payal D, Side, Lucy E, Simard, Jacques, Singer, Christian F, Steinemann, Doris, Stoppa-Lyonnet, Dominique, Tan, Yen Yen, Teixeira, Manuel R, Terry, Mary Beth, Thomassen, Mads, Tischkowitz, Marc, Tognazzo, Silvia, Toland, Amanda E, Tung, Nadine, van Asperen, Christi J, van Engelen, Klaartje, van Rensburg, Elizabeth J, Venat-Bouvet, Laurence, Vierstraete, Jeroen, Wagner, Gabriel, Walker, Lisa, Weitzel, Jeffrey N, Yannoukakos, Drakoulis, Antoniou, Antonis C, Goldgar, David E, Olopade, Olufunmilayo I, Chenevix-Trench, Georgia, Rebbeck, Timothy R, Huo, Dezheng

المساهمون: 1 Department of Medicine, University of Chicago, Chicago, IL, USA. 2 Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 3 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. 4 Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA. 5 Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 6 Department of Clinical Genetics, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands. 7 Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 8 Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. 9 Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland. 10 School of Medicine, University of Iceland, Reykjavik, Iceland. 11 North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK. 12 Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 13 Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada. 14 Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. 15 Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. 16 Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. 17 Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 18 Division Laboratories, Pharmacy and Biomedical Genetics, Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. 19 Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 20 Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, UK. 21 Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. 22 Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. 23 Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. 24 Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. 25 Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. 26 Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. 27 Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. 28 Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden. 29 Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 30 Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain. 31 Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA. 32 Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. 33 Section of Molecular Genetics, Dept. of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy. 34 Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. 35 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. 36 Department of Gynaecological Oncology, Chris O'Brien Lifehouse and The University of Sydney, Camperdown, NSW, Australia. 37 CRCHU de Québec- oncologie, Centre des maladies du sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec, QC, Canada. 38 Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA. 39 Centre for Medical Genetics, Ghent University, Gent, Belgium. 40 Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. 41 Service de Génétique, CHU de Besançon, Besançon, France. 42 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. 43 Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. 44 Unité d'Oncogénétique, ICO-Centre René Gauducheau, Saint Herblain, France. 45 Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain. 46 Department of Genetics, University of Pretoria, Arcadia, South Africa. 47 Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK. 48 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. 49 Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. 50 Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. 51 Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. 52 Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. 53 Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France. 54 Centre de Génétique, CHU Dijon, Dijon, France. 55 Molecular Diagnostic Unit, Hereditary Cancer Program, ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Barcelona, Spain. 56 Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. 57 The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel. 58 Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. 59 Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, CA, USA. 60 Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA. 61 Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. 62 Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS, USA. 63 Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. 64 Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. 65 Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia. 66 Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA. 67 The University of Chicago Pritzker School of Medicine, Chicago, IL, USA. 68 N.N. Petrov Institute of Oncology, St. Petersburg, Russia. 69 Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. 70 Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK. 71 Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland. 72 Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania. 73 State Research Institute, Innovative Medicine Center, Vilnius, CA, Lithuania. 74 Department of Medicine, Division of Oncology, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. 75 Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 76 Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 77 Département de Génétique, CHU de Grenoble, Grenoble, France. 78 Genetic Epidemiology of Cancer team, Inserm U900, Paris, France. 79 Institut Curie, Paris, France. 80 Mines ParisTech, Fontainebleau, France. 81 Department of Clinical Genetics, Amsterdam UMC, Location VU University Medical Center, Amsterdam, The Netherlands. 82 Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany. 83 NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA. 84 Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. 85 Service de Génétique, Institut Curie, Paris, France. 86 Clinical Cancer Genomics, City of Hope, Duarte, CA, USA. 87 Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. 88 Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 89 Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 90 Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. 91 Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. 92 Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. 93 West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK. 94 Department of Genetics, University Medical Center Groningen, University Groningen, Groningen, The Netherlands. 95 Department of Molecular Medicine, University La Sapienza, Rome, Italy. 96 Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. 97 Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. 98 Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. 99 Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. 100 School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, NSW, Australia. 101 The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW, Australia. 102 Clinical Genetics, Karolinska Institutet, Stockholm, Sweden. 103 Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. 104 Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA. 105 Wexner Medical Center, The Ohio State University, Columbus, OH, USA. 106 Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA. 107 Wessex Clinical Genetics Service, University Hospitals Southampton NHS Trust, Southampton, UK. 108 Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Québec City, QC, Canada. 109 Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. 110 Department of Tumour Biology, INSERM U830, Paris, France. 111 Université Paris Descartes, Paris, France. 112 Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. 113 Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. 114 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. 115 Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark. 116 Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada. 117 Department of Medical Genetics, University of Cambridge, Cambridge, UK. 118 Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. 119 Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 120 Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. 121 Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. 122 Department of Medical Oncology, CHU Dupuytren, Limoges, France. 123 Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK. 124 Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece. 125 Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. 126 Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA. 127 Harvard T.H. Chan School of Public Health, Boston, MA, USA. 128 Dana-Farber Cancer Institute, Boston, MA, USA. 129 Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA. dhuo@health.bsd.uchicago.edu. 130 Department of Public Health Sciences, University of Chicago, Chicago, IL, USA. dhuo@health.bsd.uchicago.edu.

المصدر: British journal of cancer

مصطلحات موضوعية: Eggjastokkar, Krabbamein, Gen, Líkamsþyngdarstuðull, Líkamsþyngd, Líkamshæð, Body Mass Index, Body Height, Ovarian Neoplasms, Genes, BRCA1, BRCA2

Relation: https://www.nature.com/articles/s41416-019-0492-8; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738050/; Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. 2019, 121(2):180-192 Br J Cancer; http://hdl.handle.net/2336/621058; British Journal of Cancer

الاتاحة: http://hdl.handle.net/2336/621058
https://doi.org/10.1038/s41416-019-0492-8

View record in BASE

Full Text Finder

5

Academic Journal

Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients

المؤلفون: Lemarié, C, Legeay, C, Mahieu, R, Moal, F, Ramont, C, Kouatchet, A, Eveillard, M

المساهمون: Laboratoire de Bactériologie CHU Angers, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales CHU Angers, ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Département de Pharmacie CHU d'Angers, Service de médecine intensive - réanimation et médecine hyperbare CHU Angers

المصدر: ISSN: 0195-6701.

مصطلحات موضوعية: Carbapenemase-producing Enterobacterales, Cross-transmission, Environment, Intensive care, Widespread contamination, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/33636255; inserm-03338878; https://inserm.hal.science/inserm-03338878; https://inserm.hal.science/inserm-03338878/document; https://inserm.hal.science/inserm-03338878/file/Eveillard2021Eq06.pdf; PUBMED: 33636255

الاتاحة: https://inserm.hal.science/inserm-03338878
https://inserm.hal.science/inserm-03338878/document
https://inserm.hal.science/inserm-03338878/file/Eveillard2021Eq06.pdf
https://doi.org/10.1016/j.jhin.2021.02.016

View record in BASE

6

Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients

المؤلفون: Achille Kouatchet, F. Moal, Clément Legeay, Rafael Mahieu, Catherine Ramont, Carole Lemarié, Matthieu Eveillard

المساهمون: Laboratoire de Bactériologie [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Département de Pharmacie [CHU d'Angers], Service de médecine intensive - réanimation et médecine hyperbare [CHU Angers], Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: Journal of Hospital Infection
Journal of Hospital Infection, WB Saunders, 2021, 112, pp.16-20. ⟨10.1016/j.jhin.2021.02.016⟩
Journal of Hospital Infection, 2021, 112, pp.16-20. ⟨10.1016/j.jhin.2021.02.016⟩

مصطلحات موضوعية: Microbiology (medical), medicine.medical_specialty, Hospitalized patients, Cross-transmission, viruses, Carbapenemase-producing Enterobacterales, [SDV.CAN]Life Sciences [q-bio]/Cancer, Environment, 030501 epidemiology, beta-Lactamases, law.invention, Disease Outbreaks, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, stomatognathic system, Bacterial Proteins, law, Intensive care, Enterobacterales, medicine, Humans, 0303 health sciences, Widespread contamination, urogenital system, 030306 microbiology, business.industry, Enterobacteriaceae Infections, Outbreak, General Medicine, Carbapenemase producing, biochemical phenomena, metabolism, and nutrition, Contamination, 3. Good health, Intensive Care Units, Infectious Diseases, Transmission (mechanics), Carriage, Emergency medicine, 0305 other medical science, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad3e71aab1d3d6d8101fad76aef67a9
https://pubmed.ncbi.nlm.nih.gov/33636255

View record in OpenAIRE

7

Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units

المؤلفون: Sylvie Joron, Stéphane Marret, Fabrice Lapeyre, Jérôme Larche, Jacqueline Grando, David Leyssene, Jean Nakhleh, Clarisse Dupin, Tania Foucan, Stéphanie Bordes-Couecou, Géraldine Abadie, Franck Labbe, Marie Kempf, Manuel Petitfrere, Audrey Robine, Marie Decalonne, Chantal Chaplain, Philippe Jouvencel, Florent Goube, Benjamin Cotte, Laurent Villeneuve, Adeline Lacazette, Raoul Baron, Jean-Marc Jellimann, Anne-Sophie Trentesaux, Nathalie Chautemps, Laurent Mereghetti, Olivier Dauwalder, Nicolas Fortineau, Christine Roques Ceschin, Rafik Ben Ammar, Sandra Bourdon, Alain Gravet, Audrey Glanard, Olivier Belmonte, Jacques Gilquin, Arnaud Florentin, Souad Slimani, Annick Lefebvre, Jérôme Guinard, Edith Malpote, Céline Chatelet, Isabelle Bauvin, Alain Lozniewski, Anaëlle Muggeo, Geneviève Héry-Arnaud, Stéphane Le Vu, Isabelle Ligi, Anne Le Pourhiennec, Christian Cattoen, Olivier Join-Lambert, Bruno Pozetto, Carole De Chillaz, Amine Siali, Pascale Martres, Michel Drancourt, Claire Lesteven, Sandra C. dos Santos, Nadège Bourgeois-Nicolaos, Aude Davy, Claude Olive, Rémi Gimenes, Laure Gibert, Raymond Ruimy, Virginie Morange, Antoine Bouissou, Julien Mourdie, Emmanuelle Bille, Marie-Noëlle Noulard, Vincent Cattoir, Martine Delorme, Dominique Trivier, Luc Desfrere, Hugues Patural, Patrick Barthelemy, Nadia Idri, Florence Lemann, Franck-Olivier Mallaval, Sophie Ketterer-Martinon, Christian Vandenbussche, Pierre Frange, Sylvie Ledru, Mouna Khecharem, Pierre Lureau, Sophie Boyer, Philippe Berthelot, Salma Ben Hadj Yahia, Clément Legeay, Emilie Benabid, Guillaume Menard, Marion Levast-Raffin, Céline Coroller-Bec, Claire Huart, Maryvonne Demasure, Pascal Bolot, Yasmina Berrouane, Hélène Cormier, Pascale Minery, Pascale Penn, Peggy Larroude, Evelyne Werner, Géraldine Gascoin, Virginie Forget, Nathalie van der Mee-Marquet, Stéphanie Soive, Karine Gambarotto, Vanina Ambrogi, Aurore Claudinon, Serge Klosowski, Brigitte Riviere, Véronique Merle, Laura Menvielle, Véronique Faraut-Derouin, Saïd Aberrane, Alain Beuchee, Nolwenn Le Sache

المساهمون: Hôpital Bretonneau, CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre hospitalier Félix-Guyon [Saint-Denis, La Réunion], Centre Hospitalier René Dubos [Pontoise], Centre Hospitalier Intercommunal de Créteil (CHIC), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre hospitalier de Pau, Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier de Calais, Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), CHU Pontchaillou [Rennes], Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier de Saint-Denis [Ile-de-France], Centre Hospitalier de la Côte Basque (CHCB), Groupe Hospitalier du Havre, Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Centre hospitalier [Valenciennes, Nord], Centre Hospitalier Universitaire [Rennes], GHT de l'Artois, Centre Hospitalier Victor Dupouy, Centre Hospitalier Métropole Savoie [Chambéry], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Le Mans (CH Le Mans), Clinique du Val d'Ouest, CHU Necker - Enfants Malades [AP-HP], Hospices Civils de Lyon (HCL), Centre hospitalier Saint-Brieuc, Centre Hospitalier Georges Renon [Niort] (CH Georges Renon Niort), Centre Hospitalier Régional d'Orléans (CHRO), Hôpital Louis Mourier - AP-HP [Colombes], Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), CHU de Saint-Brieuc, Interactions Gènes-Risques environnementaux et Effets sur la Santé (INGRES), Université de Lorraine (UL), Unité de Recherche Environnement Physique de la plante Horticole (EPHOR), Université d'Angers (UA)-AGROCAMPUS OUEST, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), CHU Pointe-à-Pitre/Abymes [Guadeloupe], Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Hôpital Hôtel-Dieu [Paris], Hôpital Delafontaine, Centre Hospitalier de Mulhouse, site du Hasenrain (Mulhouse), Laboratoire Universitaire de Biodiversité et Ecologie Microbienne (LUBEM), Université de Brest (UBO), Service de réanimation néonatale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Pathogénie des infections systémiques (UMR_S 570), Centre Régional de PharmacoVigilance Nord-Pas-de-Calais [CHU Lille] (CRPV), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Faculté de Médecine Henri Warembourg - Université de Lille, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de la Martinique [Fort de France], Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) (GHH), Polyclinique Médipôle Saint-Roch [Cabestany], Centre Hospitalier Universitaire de Reims (CHU Reims), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Université d'Auvergne - Clermont-Ferrand I (UdA), Aix-Marseille Université - École de médecine (AMU SMPM MED), Aix-Marseille Université - Faculté des sciences médicales et paramédicales (AMU SMPM), Aix Marseille Université (AMU)-Aix Marseille Université (AMU), Service de microbiologie [CHU Nancy], Service psychiatrique de l'enfant et de l'adolescent [CHU Hôpital Robert Debré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré, Service de bactériologie-virologie [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Infectiologie et Santé Publique (UMR ISP), Université de Tours (UT)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Registre EPIMAD, Normandie Université (NU)-Normandie Université (NU)-CHU Amiens-Picardie-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Pathogénie des Staphylocoques – Staphylococcal Pathogenesis (StaPath), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Groupe Hospitalier Artois-Ternois Centre Hospitalier d’Arras, Système Nerveux Autonome - Epidémiologie, Physiologie, Ingénierie, Santé (SNA - EPIS), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)-Université Jean Monnet - Saint-Étienne (UJM), ELSAN Polyclinique Majorelle, Centre Hospitalier Intercommunal Castres-Mazamet (CHIC-CM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Centre Hospitalier de Lens, Institut de Veille Sanitaire (INVS), Hôpital Trousseau, Jonchère, Laurent, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Le CHCB, Centre Hospitalier de la Côte Basque, Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Système Nerveux Autonome - Epidémiologie, Physiologie, Ingénierie, Santé (SNA-EPIS), Université Jean Monnet - Saint-Étienne (UJM)-Centre Hospitalier Universitaire de Saint-Etienne, CHU Saint-Etienne, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Université de Caen Normandie (UNICAEN), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université Lille 2 - Faculté de Médecine, Université de Tours-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Amiens-Picardie, Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Université Jean Monnet [Saint-Étienne] (UJM)-Centre Hospitalier Universitaire de Saint-Etienne, CHU Toulouse [Toulouse], Centre Hospitalier Universitaire Félix-Guyon [Saint-Denis, La Réunion, France], Centre Hospitalier Universitaire de Toulouse, Department of Microbiology Brest, Department of Microbiology, Brest, CHU CLAMART, Centre Hospitalier Universitaire de Nice (CHU de Nice), Centre Hospitalier Côte Basque, Bayonne, CHU Le Havre, Laboratory of microbiology and infection control, Assistance publique-Hôpitaux de Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire Charles Nicolle, Partenaires INRAE, CHU de la Réunion, Saint-Denis, France., CHU Lens, CHU Argenteuil, Centre Hospitalier Métropole Savoie-Site de Chambéry, La Clinique du Val d'Ouest, Hôpitaux Est Hôpital Louis Pradel - Hospices Civils de Lyon, Centre Hospitalier Régional d'Orléans (CHR), Hopital Louis Mourier - AP-HP [Colombes], Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU), Service de virologie, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CHU Pontchaillou [Rennes], Hôpital Antoine Béclère, Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Bactériologie-Virologie, Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d'infectiologie Necker-Pasteur [CHU Necker], Service de chirurgie infantile, CHU Felix Guyon, Saint Denis de La Réunion, Hôtel-Dieu, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu, Unité d'Hygiène Hospitalière, hospices civils de Lyon, Hôpital du Hasenrain, Mulhouse, CHU Valenciennes, Université Henri Poincaré - Nancy 1 (UHP), Hôpital de Bayonne [Bayonne], CHU Kremlin-Bicétre, Anofel Cryptosporidium National Network, Polyclinique de St Roch, CHU Pau, Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Division of Neonatology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille and Faculté de Médecine, Université de la Méditerranée - Aix-Marseille 2, Laboratoire de Microbiologie clinique et environnementale [Pointe-à-Pitre, Guadeloupe, France], Centre Hospitalier Universitaire de Rennes (CHU Rennes), Hôpital privé de l'Estuaire [Le Havre], Pathogénie des Staphylocoques – Staphylococcal Pathogenesis, Hôpital d'Arras, CHU Le MAns, Polyclinique Majorelle, Laboratoire de Microbiologie, Centre Hospitalier Intercommunal Castres-Mazamet, Laboratoire de bactériologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), Laboratoire de Recherche Opérationnelle et Mathématiques de la Décision - LAROMAD (Alger, Algérie), Centre Hospitalier d’Arras, Unité de Méthodologie en Recherche Clinique, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)

المصدر: European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, 2020, 39 (11), pp.2185-94. ⟨10.1007/s10096-020-03925-5⟩
European Journal of Clinical Microbiology & Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2020, 39 (11), pp.2185-94. ⟨10.1007/s10096-020-03925-5⟩
European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2020, ⟨10.1007/s10096-020-03925-5⟩

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfaafedb7b1955f5f0bb8ab2b56b304
https://amu.hal.science/hal-02868692/document

View record in OpenAIRE

8

Academic Journal

Conclusions of the French Food Safety Agency on the toxicity of bisphenol A

المؤلفون: Arnich, Nathalie, Canivenc-Lavier, Marie-Chantal, Kolf-Clauw, Martine, Coffigny, Hervé, Cravedi, Jean Pierre, J. P., Grob, Konrad, Macherey, Anne-Christine, Masset, Dominique, Maximilien, Rémi, Narbonne, Jean-François, Nesslany, Fabrice, Stadler, Jeanne, Tulliez, Jacques

المساهمون: Agence Française de Sécurité Sanitaire des Aliments, Centre des Sciences du Goût et de l'Alimentation Dijon (CSGA), Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB)-Centre National de la Recherche Scientifique (CNRS), ToxAlim (ToxAlim), Institut National de la Recherche Agronomique (INRA)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Ecole d'Ingénieurs de Purpan (INP - PURPAN), Université de Toulouse (UT)-Université de Toulouse (UT), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Official Food Control Authority Canton of Zurich, Unité de Prévention du Risque Chimique, Centre National de la Recherche Scientifique (CNRS), AFSSAPS, Laboratoire de Toxicologie Biochimique, Université Sciences et Technologies - Bordeaux 1 (UB), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)

المصدر: ISSN: 1438-4639 ; International Journal of Hygiene and Environmental Health ; https://hal.science/hal-01594322 ; International Journal of Hygiene and Environmental Health, 2011, 214 (3), pp.271-275. ⟨10.1016/j.ijheh.2010.12.002⟩.

مصطلحات موضوعية: Bisphenol A, BPA, Risk assessment, Toxicity, Endocrine disruptors, [SDV]Life Sciences [q-bio]

Relation: PRODINRA: 164569; WOS: 000293814600014

الاتاحة: https://hal.science/hal-01594322
https://hal.science/hal-01594322v1/document
https://hal.science/hal-01594322v1/file/Arnich_IntJHygEnvHea2011_%7B0D5F2889-6878-4E96-9992-C26A89F8C7B2%7D.pdf
https://doi.org/10.1016/j.ijheh.2010.12.002

View record in BASE

9

Book

L'éducation pour la santé en médecine générale : de la fonction curative à la fonction éducative : Université d'été, Château de Mialaret, Corrèze, du 4 au 7 juillet 1996 / sous la dir. de Brigitte Sandrin Berthon, Isabelle Aujoulat, Corine Ottenheim. [et al.] ; [organisée par le] Comité français d'éducation pour la santé ; [le] Comité d'éducation pour la santé d'Eure-et-Loir [et l'] Unité de prévention et d'éducation de l'hôpital de Dreux

المساهمون: Hôpital général Victor Jousselin (Dreux, Eure-et-Loir). Unité de prévention et d'éducation. Éditeur scientifique, Comité départemental d'éducation pour la santé (Eure-et-Loir). Éditeur scientifique

المصدر: Bibliothèque nationale de France, département Sciences et techniques, 8-D3 MON-2813

مصطلحات موضوعية: Éducation sanitaire -- France, Relations médecin-patient

وصف الملف: 1 vol. (175 p.) : ill., couv. ill. en coul.; 24 cm; Nombre total de vues : 180

Relation: Notice du catalogue : http://catalogue.bnf.fr/ark:/12148/cb361872170; http://gallica.bnf.fr/ark:/12148/bpt6k3326505h

الاتاحة: http://gallica.bnf.fr/ark:/12148/bpt6k3326505h

View record in BASE

10

Academic Journal

Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort.

المؤلفون: Bénard, Antoine, Bonnet, Fabrice, Tessier, Jean-François, Fossoux, Hélène, Dupon, Michel, Mercié, Patrick, Ragnaud, Jean-Marie, Viallard, Jean-François, Dabis, François, Chêne, Geneviève, Aquitaine, Groupe d'Épidémiologie Clinique Du Sida En, Gecsa

المساهمون: Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux, Service de médecine interne et maladies tropicales, CHU Bordeaux-Groupe hospitalier Saint-André, Service de maladies respiratoires, unité de prévention et d'aide au sevrage tabagique, Service des maladies infectieuses, CHU Bordeaux-Groupe hospitalier Pellegrin, Service de médecine interne, CHU Bordeaux-Hôpital Saint-André, Service de médecine interne A

المصدر: ISSN: 1087-2914.

مصطلحات موضوعية: HIV Infections, Tobacco Use Disorders, Depressive Disorder, Motivation, Tobacco Use Cessation, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/17651027; inserm-00168599; https://inserm.hal.science/inserm-00168599; https://inserm.hal.science/inserm-00168599/document; https://inserm.hal.science/inserm-00168599/file/Benard_AIDS-Patient.pdf; PUBMED: 17651027

الاتاحة: https://inserm.hal.science/inserm-00168599
https://inserm.hal.science/inserm-00168599/document
https://inserm.hal.science/inserm-00168599/file/Benard_AIDS-Patient.pdf
https://doi.org/10.1089/apc.2006.0142

View record in BASE

11

High prevalence of contamination of sink drains with carbapenemase-producing Enterobacteriaceae in 4 intensive care units apart from any epidemic context

المؤلفون: Rafael Mahieu, Achille Kouatchet, Marie Kempf, Carole Lemarié, Matthieu Eveillard, Pamela Holecska, Maxime Corre, Laura Onillon, Sigismond Lasocki, C. Legeay

المساهمون: Laboratoire de Bactériologie [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], Service de médecine intensive - réanimation et médecine hyperbare [CHU Angers], ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), PRES Université Nantes Angers Le Mans (UNAM), Service de Réanimation Chirurgicale [CHU Angers], Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: American Journal of Infection Control
American Journal of Infection Control, Elsevier, 2019, Epub ahead of print. ⟨10.1016/j.ajic.2019.08.007⟩
American Journal of Infection Control, 2019, Epub ahead of print. ⟨10.1016/j.ajic.2019.08.007⟩

مصطلحات موضوعية: Carbapenem resistant bacteria, Carbapenemase-Producing Enterobacteriaceae, Epidemiology, Hospitalized patients, Resistance genes, [SDV.CAN]Life Sciences [q-bio]/Cancer, Sink (geography), 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Intensive care, Environmental health, Drug Resistance, Multiple, Bacterial, Medicine, Humans, 030212 general & internal medicine, Environmental reservoir, 0303 health sciences, geography, High prevalence, geography.geographical_feature_category, 030306 microbiology, business.industry, Health Policy, Public Health, Environmental and Occupational Health, biochemical phenomena, metabolism, and nutrition, Contamination, Carbapenem-resistant bacteria, Polymerase chain reaction, 3. Good health, Anti-Bacterial Agents, Critical care, Intensive Care Units, Infectious Diseases, Carriage, Carbapenem-Resistant Enterobacteriaceae, Equipment Contamination, Sanitary Engineering, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ae5beb708bcf35dfc553027f5c05d2
https://pubmed.ncbi.nlm.nih.gov/31495643

View record in OpenAIRE

12

Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in intensive care units: strong correlation with the ESBLE colonization pressure in patients but not same species

المؤلفون: Maxime Corre, Matthieu Eveillard, L Bahier, Laura Onillon, Carole Lemarié, Sigismond Lasocki, Rafael Mahieu, Marie Kempf, Achille Kouatchet, Clément Legeay

المساهمون: Laboratoire de Bactériologie [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], Service de Réanimation Chirurgicale [CHU Angers], ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Service de médecine intensive - réanimation et médecine hyperbare [CHU Angers], Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: Journal of Hospital Infection
Journal of Hospital Infection, WB Saunders, 2019, Epub ahead of print. ⟨10.1016/j.jhin.2019.08.007⟩
Journal of Hospital Infection, 2019, Epub ahead of print. ⟨10.1016/j.jhin.2019.08.007⟩

مصطلحات موضوعية: Microbiology (medical), Colonization pressure, Veterinary medicine, [SDV.CAN]Life Sciences [q-bio]/Cancer, 030501 epidemiology, beta-Lactamases, 03 medical and health sciences, Citrobacter, [SDV.CAN] Life Sciences [q-bio]/Cancer, Enterobacteriaceae, Intensive care, Drug Resistance, Multiple, Bacterial, Surveys and Questionnaires, Medicine, Humans, Colonization, In patient, Extended-spectrum-beta-lactamase, 0303 health sciences, Cross Infection, biology, 030306 microbiology, business.industry, Bacterial dissemination, Enterobacteriaceae Infections, General Medicine, biology.organism_classification, Intensive Care Units, Klebsiella pneumoniae, Infectious Diseases, Carriage, Carbapenem-Resistant Enterobacteriaceae, Carrier State, France, 0305 other medical science, business, Sink drain

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c5ab746a3763bdd6887b15c2d490d6
https://pubmed.ncbi.nlm.nih.gov/31408692

View record in OpenAIRE

13

Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations

المساهمون: Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Laboratoire d'Oncologie Moléculaire, Unité de Prévention et de Dépistage des Cancers, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER-UNICANCER, Université Paul-Valéry - Montpellier 3 (UPVM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)

المصدر: Psycho-Oncology
Psycho-Oncology, Wiley, 2019, 28 (8), pp.1679-1686. ⟨10.1002/pon.5142⟩

مصطلحات موضوعية: Proband, Adult, Male, Coping (psychology), congenital, hereditary, and neonatal diseases and abnormalities, [SDV]Life Sciences [q-bio], Experimental and Cognitive Psychology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disclosure, Gene mutation, DNA Mismatch Repair, 03 medical and health sciences, 0302 clinical medicine, BRCA 1, Alexithymia, BRCA 2, Medicine, cancer, Humans, Family, Genetic Predisposition to Disease, 030212 general & internal medicine, Genetic Testing, Family history, genes, Genetic testing, BRCA2 Protein, medicine.diagnostic_test, business.industry, BRCA1 Protein, Middle Aged, medicine.disease, 3. Good health, Psychiatry and Mental health, 030220 oncology & carcinogenesis, oncology, Mutation, Anxiety, Female, medicine.symptom, business, Psychosocial, Clinical psychology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64310d4d9d5e36cf87033fef2114613c
https://pubmed.ncbi.nlm.nih.gov/31152683

View record in OpenAIRE

14

Academic Journal

Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in intensive care units: strong correlation with the ESBLE colonization pressure in patients but not same species

المؤلفون: Lemarié, Carole, Legeay, Clément, Lasocki, Sigismond, Mahieu, Rafael, Kouatchet, Achille, Bahier, Laure, Onillon, Laura, Corre, Maxime, Kempf, Marie, Eveillard, Matthieu

المساهمون: Laboratoire de Bactériologie CHU Angers, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales CHU Angers, Service de Réanimation Chirurgicale CHU Angers, ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Service de médecine intensive - réanimation et médecine hyperbare CHU Angers

المصدر: ISSN: 0195-6701.

مصطلحات موضوعية: Bacterial dissemination, Colonization pressure, Extended-spectrum-beta-lactamase, Klebsiella pneumoniae, Sink drain, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/31408692; inserm-02298265; https://inserm.hal.science/inserm-02298265; https://inserm.hal.science/inserm-02298265/document; https://inserm.hal.science/inserm-02298265/file/Eveillard2019Eq6.pdf; PUBMED: 31408692

الاتاحة: https://inserm.hal.science/inserm-02298265
https://inserm.hal.science/inserm-02298265/document
https://inserm.hal.science/inserm-02298265/file/Eveillard2019Eq6.pdf
https://doi.org/10.1016/j.jhin.2019.08.007

View record in BASE

15

Academic Journal

Contamination of sink drains with carbapenemase-producing Enterobacteriaceae in intensive care units: a concern but don't worry so much!

المؤلفون: Eveillard, M., Lemarié, C., Legeay, C., Ramont, C., Onillon, L., Corre, M., Lasocki, S.

المساهمون: Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Laboratoire de Bactériologie CHU Angers, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales CHU Angers, Service d'anesthésie et réanimation chirurgicale

المصدر: ISSN: 0195-6701.

مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/31419469; inserm-02298328; https://inserm.hal.science/inserm-02298328; https://inserm.hal.science/inserm-02298328/document; https://inserm.hal.science/inserm-02298328/file/EveillardB2019Eq6.pdf; PUBMED: 31419469

الاتاحة: https://inserm.hal.science/inserm-02298328
https://inserm.hal.science/inserm-02298328/document
https://inserm.hal.science/inserm-02298328/file/EveillardB2019Eq6.pdf
https://doi.org/10.1016/j.jhin.2019.08.009

View record in BASE

16

Academic Journal

High prevalence of contamination of sink drains with carbapenemase-producing Enterobacteriaceae in 4 intensive care units apart from any epidemic context

المؤلفون: Lemarié, Carole, Legeay, Clément, Kouatchet, Achille, Mahieu, Rafael, Lasocki, Sigismond, Holecska, Pamela, Onillon, Laura, Corre, Maxime, Kempf, Marie, Eveillard, Matthieu

المساهمون: Laboratoire de Bactériologie CHU Angers, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales CHU Angers, Service de médecine intensive - réanimation et médecine hyperbare CHU Angers, ATOMycA (CRCINA-ÉQUIPE 6), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), PRES Université Nantes Angers Le Mans (UNAM), Service de Réanimation Chirurgicale CHU Angers

المصدر: ISSN: 0196-6553 ; American Journal of Infection Control ; https://inserm.hal.science/inserm-02298350 ; American Journal of Infection Control, 2019, Epub ahead of print. ⟨10.1016/j.ajic.2019.08.007⟩.

مصطلحات موضوعية: Resistance genes, Polymerase chain reaction, Environmental reservoir, Critical care, Carbapenem-resistant bacteria, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/31495643; inserm-02298350; https://inserm.hal.science/inserm-02298350; https://inserm.hal.science/inserm-02298350/document; https://inserm.hal.science/inserm-02298350/file/EveillardC2019Eq6.pdf; PUBMED: 31495643

الاتاحة: https://inserm.hal.science/inserm-02298350
https://inserm.hal.science/inserm-02298350/document
https://inserm.hal.science/inserm-02298350/file/EveillardC2019Eq6.pdf
https://doi.org/10.1016/j.ajic.2019.08.007

View record in BASE

17

Academic Journal

Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations

المساهمون: Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD France-Sud ), Laboratoire d'Oncologie Moléculaire, Unité de Prévention et de Dépistage des Cancers, Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER-UNICANCER, Université Paul-Valéry - Montpellier 3 (UPVM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)

المصدر: ISSN: 1057-9249.

مصطلحات موضوعية: BRCA 1, BRCA 2, cancer, disclosure, DNA mismatch repair, family, genes, genetic testing, mutation, oncology, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: hal-02527391; https://hal.umontpellier.fr/hal-02527391

الاتاحة: https://hal.umontpellier.fr/hal-02527391
https://doi.org/10.1002/pon.5142

View record in BASE

18

Contamination of sink drains with carbapenemase-producing Enterobacteriaceae in intensive care units: a concern but don't worry so much!

المؤلفون: Clément Legeay, Maxime Corre, Laura Onillon, Sigismond Lasocki, Matthieu Eveillard, Catherine Ramont, Carole Lemarié

المساهمون: Bernardo, Elizabeth, Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Laboratoire de Bactériologie [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], Service d'anesthésie et réanimation chirurgicale, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)

المصدر: Journal of Hospital Infection
Journal of Hospital Infection, 2019, pp.30321-4. ⟨10.1016/j.jhin.2019.08.009⟩
Journal of Hospital Infection, WB Saunders, 2019, pp.30321-4. ⟨10.1016/j.jhin.2019.08.009⟩

مصطلحات موضوعية: Microbiology (medical), Carbapenemase-Producing Enterobacteriaceae, media_common.quotation_subject, [SDV.CAN]Life Sciences [q-bio]/Cancer, Carbapenem-resistant enterobacteriaceae, Sink (geography), beta-Lactamases, Disease Outbreaks, Hospitals, University, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Environmental health, Intensive care, Environmental Microbiology, Medicine, Humans, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, media_common, 0303 health sciences, geography, Bacteriological Techniques, geography.geographical_feature_category, Waste management, 030306 microbiology, business.industry, General Medicine, Contamination, Electrophoresis, Gel, Pulsed-Field, Klebsiella Infections, Klebsiella pneumoniae, Intensive Care Units, Infectious Diseases, Carbapenem-Resistant Enterobacteriaceae, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, France, Worry, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbc8a639af7cd58933f98e17187d24e
https://www.hal.inserm.fr/inserm-02298328

View record in OpenAIRE

19

Academic Journal

Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience

المؤلفون: Legeay, Clément, Thépot-Seegers, V, Pailhories, Hélène, Hilliquin, D, Zahar, J-R

المساهمون: Unité de prévention et de lutte contre les infections nosocomiales CHU Angers, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Innate Immunity and Immunotherapy (CRCINA-ÉQUIPE 7), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), PRES Université Nantes Angers Le Mans (UNAM), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 0195-6701.

مصطلحات موضوعية: Cross Infection, Disease Outbreaks, Disease Transmission, Infectious, Enterobacteriaceae Infections, Female, Humans, Infection Control, Male, Middle Aged, Prospective Studies, Young Adult, Adult, Aged, 80 and over, Carbapenem-Resistant Enterobacteriaceae, [SDV]Life Sciences [q-bio]

Relation: OKINA: ua20043

الاتاحة: https://univ-angers.hal.science/hal-02874607
https://doi.org/10.1016/j.jhin.2018.02.003

View record in BASE

20

Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience

المؤلفون: Valérie Thépot-Seegers, Jean-Ralph Zahar, C. Legeay, Hélène Pailhoriès, D. Hilliquin

المساهمون: Unité de prévention et de lutte contre les infections nosocomiales [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Innate Immunity and Immunotherapy (CRCINA-ÉQUIPE 7), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), PRES Université Nantes Angers Le Mans (UNAM)

المصدر: The Journal of hospital infection
The Journal of hospital infection, 2018, 99, pp.390-395. ⟨10.1016/j.jhin.2018.02.003⟩

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), Adult, Male, medicine.medical_specialty, Multivariate analysis, media_common.quotation_subject, [SDV]Life Sciences [q-bio], 030106 microbiology, 030501 epidemiology, law.invention, Disease Outbreaks, 03 medical and health sciences, Young Adult, Disease Transmission, law, Hygiene, Disease Transmission, Infectious, 80 and over, Medicine, Antimicrobial stewardship, Infection control, Humans, Prospective Studies, media_common, Aged, Aged, 80 and over, Cross Infection, Infection Control, business.industry, Infectious, Enterobacteriaceae Infections, General Medicine, Odds ratio, Middle Aged, Confidence interval, 3. Good health, Infectious Diseases, Transmission (mechanics), Carbapenem-Resistant Enterobacteriaceae, Cohort, Emergency medicine, Female, 0305 other medical science, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6248403712d0f8f673017c5b23d47594
https://hal.univ-angers.fr/hal-02874607

View record in OpenAIRE

تنقيح النتائج